肝脏药物乙酰化和氧化：衰老对人体的影响。
Hepatic drug acetylation and oxidation: effects of aging in man.
作者信息
Farah F, Taylor W, Rawlins M D, James O
出版信息
Br Med J. 1977 Jul 16;2(6080):155-6. doi: 10.1136/bmj.2.6080.155.
Abstract
The half lives of acetanilide and isoniazid ("model" substrates for oxidation and acetylation respectively) were measured in populations of young (aged 20-35 years) and elderly (aged over 65 years) people. Whereas acetanilide half lives were significantly longer in the elderly, isoniazid half lives were distributed similarly in both populations. The results suggest that liver function does not decline uniformly with age and that heterozygotes for acetylation do not possess survival advantages during their middle years of life.
摘要
在年轻人群（20 - 35岁）和老年人群（65岁以上）中测量了乙酰苯胺和异烟肼（分别作为氧化和乙酰化的“模型”底物）的半衰期。乙酰苯胺的半衰期在老年人中显著更长，而异烟肼的半衰期在这两个人群中的分布相似。结果表明，肝功能不会随年龄均匀下降，并且乙酰化杂合子在中年时期并不具有生存优势。
相似文献
1
Hepatic drug acetylation and oxidation: effects of aging in man.肝脏药物乙酰化和氧化：衰老对人体的影响。
Br Med J. 1977 Jul 16;2(6080):155-6. doi: 10.1136/bmj.2.6080.155.
2
Drug metabolism in the elderly.
Age Ageing. 1978;Suppl:81-5. doi: 10.1093/ageing/7.suppl.81.
3
Age related differences in the disposition of acetanilide.乙酰苯胺处置过程中的年龄相关差异。
Br J Clin Pharmacol. 1978 Dec;6(6):529-33. doi: 10.1111/j.1365-2125.1978.tb00878.x.
4
Sulfadimidine and isoniazid loading in man and laboratory rats. Pharmacokinetic and pharmacogenetic results on drug acetylation.
Arzneimittelforschung. 1980;30(9):1574-9.
5
Acetanilide oxidation in phenylbutazone-associated hypoplastic anaemia.保泰松相关的再生障碍性贫血中乙酰苯胺氧化作用
Br Med J. 1974 Aug 3;3(5926):313-7. doi: 10.1136/bmj.3.5926.313.
6
The acute effects of ethanol on acetanilide disposition in normal subjects, and in patients with liver disease.乙醇对正常受试者及肝病患者中乙酰苯胺处置的急性影响。
Br J Clin Pharmacol. 1982 Oct;14(4):501-4. doi: 10.1111/j.1365-2125.1982.tb02019.x.
7
Pharmacokinetics of isoniazid: influence of age.异烟肼的药代动力学：年龄的影响
Eur J Clin Pharmacol. 1986;30(3):335-40. doi: 10.1007/BF00541539.
8
Decreased acetylation of isoniazid in chronic renal failure.慢性肾衰竭中异烟肼乙酰化作用降低。
Clin Pharmacol Ther. 1993 Dec;54(6):612-20. doi: 10.1038/clpt.1993.198.
9
The effect of thyrotoxicosis on isoniazid acetylation.甲状腺毒症对异烟肼乙酰化的影响。
Br J Clin Pharmacol. 1988 Jul;26(1):103-6. doi: 10.1111/j.1365-2125.1988.tb03372.x.
10
Effects of isoniazid on hepatic drug oxidation and N-acetylation capacities in rats.
Pharmazie. 1992 Jun;47(6):448-51.
引用本文的文献
1
The effect of ageing on isoniazid pharmacokinetics and hepatotoxicity in Fischer 344 rats.衰老对费希尔344大鼠体内异烟肼药代动力学及肝毒性的影响。
Fundam Clin Pharmacol. 2016 Feb;30(1):23-34. doi: 10.1111/fcp.12157. Epub 2015 Nov 9.
2
Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol.人类乙酰化酶基因型：与结直肠癌发病率及结肠胞质溶胶中芳胺N - 乙酰转移酶表达的关系。
Arch Toxicol. 1993;67(7):445-52. doi: 10.1007/BF01969914.
3
Pharmacokinetics of isoniazid in the elderly.异烟肼在老年人中的药代动力学。
Br J Clin Pharmacol. 1980 Aug;10(2):167-9. doi: 10.1111/j.1365-2125.1980.tb01735.x.
4
Hepatic acetylator phenotype in porphyria cutanea tarda.迟发性皮肤卟啉症中的肝脏乙酰化酶表型
Arch Dermatol Res. 1981;270(2):171-3. doi: 10.1007/BF00408229.
5
The acute effects of ethanol on acetanilide disposition in normal subjects, and in patients with liver disease.乙醇对正常受试者及肝病患者中乙酰苯胺处置的急性影响。
Br J Clin Pharmacol. 1982 Oct;14(4):501-4. doi: 10.1111/j.1365-2125.1982.tb02019.x.
6
Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.异烟肼代谢、日本特发性系统性红斑狼疮患者与对照受试者的异烟肼表型分析方法比较及乙酰化酶分布
Br J Clin Pharmacol. 1982 Mar;13(3):361-74. doi: 10.1111/j.1365-2125.1982.tb01387.x.
7
Drug prescribing for the elderly.老年人的药物处方
West J Med. 1981 Dec;135(6):455-62.
8
Acetylator phenotypes: effect of age.
Eur J Clin Pharmacol. 1984;26(1):43-5. doi: 10.1007/BF00546707.
9
Benzodiazepines: clinical pharmacology and therapeutic use.苯二氮䓬类药物：临床药理学与治疗用途。
Drugs. 1980 Mar;19(3):195-219. doi: 10.2165/00003495-198019030-00004.
10
Towards rational drug therapy in old age. The F.E. Williams Lecture 1985.迈向老年合理药物治疗。1985年F.E.威廉姆斯讲座
J R Coll Physicians Lond. 1985 Oct;19(4):235-9.
本文引用的文献
1
Genetic control of isoniazid metabolism in man.人体中异烟肼代谢的遗传控制。
Br Med J. 1960 Aug 13;2(5197):485-91. doi: 10.1136/bmj.2.5197.485.
2
[Contribution to the problem of functional changes in the liver in the aging process. Changes in bromosulphthalein kinetics].
Gerontol Clin (Basel). 1968;10(1):43-57.
3
Genetic control of phenylbutazone metabolism in man.人类中保泰松代谢的遗传控制。
Br Med J. 1970 Nov 7;4(5731):323-8. doi: 10.1136/bmj.4.5731.323.
4
Correlation of subjective side effects with plasma concentrations of nortriptyline.主观副作用与去甲替林血浆浓度的相关性。
Br Med J. 1970 Oct 3;4(5726):18-21. doi: 10.1136/bmj.4.5726.18.
5
The pharmacokinetics of acetanilide and of diphenylhydantoin sodium.乙酰苯胺和苯妥英钠的药代动力学。
Eur J Clin Pharmacol. 1974 Oct 4;7(6):461-6. doi: 10.1007/BF00560359.
Zotero 插件